Kappos L - Search Results

1

Working memory training in patients with multiple sclerosis - comparison of two different training schedules.

Vogt A, Kappos L, Calabrese P, Stöcklin M, Gschwind L, Opwis K, Penner IK. Vogt A, et al. Among authors: kappos l. Restor Neurol Neurosci. 2009;27(3):225-35. doi: 10.3233/RNN-2009-0473. Restor Neurol Neurosci. 2009. PMID: 19531877

2

Computer assisted retraining of attentional impairments in patients with multiple sclerosis.

Plohmann AM, Kappos L, Ammann W, Thordai A, Wittwer A, Huber S, Bellaiche Y, Lechner-Scott J. Plohmann AM, et al. Among authors: kappos l. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):455-62. doi: 10.1136/jnnp.64.4.455. J Neurol Neurosurg Psychiatry. 1998. PMID: 9576535 Free PMC article. Clinical Trial.

3

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Leppert D, et al. Among authors: kappos l. Brain. 1998 Dec;121 ( Pt 12):2327-34. doi: 10.1093/brain/121.12.2327. Brain. 1998. PMID: 9874483

4

Visual and motor evoked potentials in the course of multiple sclerosis.

Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L. Fuhr P, et al. Among authors: kappos l. Brain. 2001 Nov;124(Pt 11):2162-8. doi: 10.1093/brain/124.11.2162. Brain. 2001. PMID: 11673318 Clinical Trial.

5

Evoked potentials for evaluation of multiple sclerosis.

Fuhr P, Kappos L. Fuhr P, et al. Among authors: kappos l. Clin Neurophysiol. 2001 Dec;112(12):2185-9. doi: 10.1016/s1388-2457(01)00687-3. Clin Neurophysiol. 2001. PMID: 11738188 Review.

6

Final analysis of the European multicenter trial on IFNbeta-1b in secondary-progressive MS.

Kappos L, Polman C, Pozzilli C, Thompson A, Beckmann K, Dahlke F; European Study Group in Interferon beta-1b in Secondary-Progressive MS. Kappos L, et al. Neurology. 2001 Dec 11;57(11):1969-75. doi: 10.1212/wnl.57.11.1969. Neurology. 2001. PMID: 11739811 Clinical Trial.

7

Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis.

Pache M, Kaiser HJ, Akhalbedashvili N, Lienert C, Dubler B, Kappos L, Flammer J. Pache M, et al. Among authors: kappos l. Eur Neurol. 2003;49(3):164-8. doi: 10.1159/000069085. Eur Neurol. 2003. PMID: 12646761

8

Analysis of impairment related functional architecture in MS patients during performance of different attention tasks.

Penner IK, Rausch M, Kappos L, Opwis K, Radü EW. Penner IK, et al. Among authors: kappos l. J Neurol. 2003 Apr;250(4):461-72. doi: 10.1007/s00415-003-1025-0. J Neurol. 2003. PMID: 12700913

9

Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.

Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans-Coutinho M, Clanet M, Radue EW, Kappos L; European rIFN beta-1a in Relapsing MS Dose Comparison Trial Study Group. Hardmeier M, et al. Among authors: kappos l. Arch Neurol. 2003 Dec;60(12):1736-9. doi: 10.1001/archneur.60.12.1736. Arch Neurol. 2003. PMID: 14676048

10

Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.

Kappos L, Weinshenker B, Pozzilli C, Thompson AJ, Dahlke F, Beckmann K, Polman C, McFarland H; European (EU-SPMS) Interferon beta-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Independent Advisory Board; North American (NA-SPMS) Interferon beta-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Independent Advisory Board. Kappos L, et al. Neurology. 2004 Nov 23;63(10):1779-87. doi: 10.1212/01.wnl.0000145561.08973.4f. Neurology. 2004. PMID: 15557490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

812 results

Search Page

Filters